Potential of artemisinin-based combination therapies to block malaria transmission
- PMID: 23468055
- PMCID: PMC4627501
- DOI: 10.1093/infdis/jit079
Potential of artemisinin-based combination therapies to block malaria transmission
Comment on
-
Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.J Infect Dis. 2013 Jun 1;207(11):1637-45. doi: 10.1093/infdis/jit077. Epub 2013 Mar 6. J Infect Dis. 2013. PMID: 23468056 Clinical Trial.
References
-
- Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet. 1996;347:1654–8. - PubMed
-
- Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000;356:297–302. - PubMed
-
- Arinaitwe E, Sandison TG, Wanzira H, et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis. 2009;49:1629–37. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources